Schedule 13G ownership disclosure

Inhibitor Therapeutics, Inc.

Security class unavailable · CUSIP: 45720M105

Event date: 2023-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-147220
Form type
SC 13G
Filer
Inhibitor Therapeutics, Inc.
CIK
CIK 1042418
Filed
May 18, 2023
Reporting period
May 05, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub